Henry Van Der Vall

COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

L. Thijs, J. Wagstaff, J. Nuijens, 1989, The Lancet.

Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 1990, Journal of immunology.